NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT03150810 2024-12-20Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsBeiGenePhase 1 Completed139 enrolled 36 charts
NCT00445965 2024-04-04Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerMemorial Sloan Kettering Cancer CenterPhase 2 Completed78 enrolled 11 charts
NCT03365791 2022-05-27PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesNovartisPhase 2 Completed76 enrolled 14 charts
NCT02062632 2019-10-01Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyMayo ClinicPhase 2 Terminated5 enrolled 4 charts
NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts